ADC Therapeutics SA (NYSE:ADCT)
| 0.8161 Delayed Data As of 11:44am ET |  -0.0081 / -0.98%Today’s Change | 0.68 Today|||52-Week Range 5.75 | -78.75% Year-to-Date |
Latest ADCT News | Press Releases
No recent news for ADC Therapeutics SA.
Today’s Trading
| Previous close | 0.82 |
| Today’s open | 0.81 |
| Day’s range | 0.81 - 0.82 |
| Volume | 114,319 |
| Average volume (3 months) | 420,550 |
| Market cap | $73.4M |
Data as of 11:44am ET, 10/03/2023
Growth & Valuation
| Earnings growth (last year) | +33.49% |
| Earnings growth (this year) | -32.77% |
| Earnings growth (next 5 years) | +15.75% |
| Revenue growth (last year) | +518.89% |
| P/E ratio | NM |
| Price/Sales | 1.43 |
| Price/Book | 0.83 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 16, 2023 |
| EPS forecast (this quarter) | -$0.69 |
| Annual revenue (last year) | $209.9M |
| Annual profit (last year) | -$155.8M |
| Net profit margin | -74.22% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
